Samsung Biologics, Foreign Investors Net Buy 20,362 Shares... Stock Price Up 0.85%
Samsung Biologics ranked among the top searched stocks for 17 days in the past month.
As of 2:32 PM on the 12th, Samsung Biologics is trading at 591,000 KRW, up 0.85% from the previous day. This marks a 23.77% increase compared to April 8. Samsung Biologics is known as the bio business holding company of the Samsung Group.
Today, foreigners have a net purchase of 20,362 shares of Samsung Biologics, and institutions have a net purchase of 3,000 shares, according to provisional data. Over the past five days, individual investors have net sold 28,091 shares, while foreigners and institutions have net bought 50,442 shares and 18,016 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: Shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Dramatic Agreement Reached on Eve of Samsung Electronics General Strike... Minister Kim Young-hoon: "Showcased Korea's Strength in Dialogue" (Update)
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
